Skip to main content
. 2016 Jul 22;15(2):63–68. doi: 10.5114/pm.2016.61186

Tab. II.

Distinct genetic alterations in type I and type II endometrial cancer (percentage is based on several publications, showing only a general tendency) [2426]

Mutation Type I Type II
PTEN 50-80% 1-10%
KRAS 20-40% 4-8%
CTNNB1 25% uncommon
PIK3CA 40-50% 20-40%
PIK3R1 20-40% < 10%
ARID1A 25-50% 5-10%
TP53 10% 80-90%
HER2 very uncommon 30-40%
MSI 30-40% uncommon
PPP2R1A < 10% 10-40%